These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 36077526)

  • 1. How Microbiota-Derived Metabolites Link the Gut to the Brain during Neuroinflammation.
    Rebeaud J; Peter B; Pot C
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
    Parodi B; Kerlero de Rosbo N
    Front Immunol; 2021; 12():718220. PubMed ID: 34621267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis.
    Bianchimano P; Britton GJ; Wallach DS; Smith EM; Cox LM; Liu S; Iwanowski K; Weiner HL; Faith JJ; Clemente JC; Tankou SK
    Microbiome; 2022 Oct; 10(1):174. PubMed ID: 36253847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the gut microbiota and microbial metabolites in neuroinflammation.
    Haase S; Wilck N; Haghikia A; Gold R; Mueller DN; Linker RA
    Eur J Immunol; 2020 Dec; 50(12):1863-1870. PubMed ID: 33188704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota Interact With the Brain Through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging.
    Mou Y; Du Y; Zhou L; Yue J; Hu X; Liu Y; Chen S; Lin X; Zhang G; Xiao H; Dong B
    Front Immunol; 2022; 13():796288. PubMed ID: 35464431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders.
    Dopkins N; Nagarkatti PS; Nagarkatti M
    Immunology; 2018 Jun; 154(2):178-185. PubMed ID: 29392733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiome Methods in Experimental Autoimmune Encephalomyelitis.
    Daberkow DP; Hoffman K; Kohl HM; Long T; Kirby TO; Ochoa-Repáraz J
    Curr Protoc; 2021 Dec; 1(12):e314. PubMed ID: 34870901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feeding the gut microbiome: impact on multiple sclerosis.
    Bronzini M; Maglione A; Rosso R; Matta M; Masuzzo F; Rolla S; Clerico M
    Front Immunol; 2023; 14():1176016. PubMed ID: 37304278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis.
    Kumar N; Sahoo NK; Mehan S; Verma B
    Mult Scler Relat Disord; 2023 Mar; 71():104547. PubMed ID: 36805171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Sclerosis and Microbiome.
    Preiningerova JL; Jiraskova Zakostelska Z; Srinivasan A; Ticha V; Kovarova I; Kleinova P; Tlaskalova-Hogenova H; Kubala Havrdova E
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.
    Freedman SN; Shahi SK; Mangalam AK
    Neurotherapeutics; 2018 Jan; 15(1):109-125. PubMed ID: 29204955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease.
    Mowry EM; Glenn JD
    Neurol Clin; 2018 Feb; 36(1):185-196. PubMed ID: 29157399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, gut microbiota, and multiple sclerosis: Unraveling the connection.
    Samara A; Cantoni C; Piccio L; Cross AH; Chahin S
    Mult Scler Relat Disord; 2023 Aug; 76():104768. PubMed ID: 37269641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin and MCC950 modified gut microbiota in experimental autoimmune encephalomyelitis mouse by brain gut axis.
    Xu L; Zhang C; He D; Jiang N; Bai Y; Xin Y
    Life Sci; 2020 Jul; 253():117747. PubMed ID: 32376270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional effects of gut microbiota-derived metabolites in Alzheimer's disease.
    Choi H; Mook-Jung I
    Curr Opin Neurobiol; 2023 Aug; 81():102730. PubMed ID: 37236067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications.
    Wang X; Liang Z; Wang S; Ma D; Zhu M; Feng J
    Curr Neuropharmacol; 2022; 20(7):1413-1426. PubMed ID: 34191698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment.
    Duarte-Silva E; Meuth SG; Peixoto CA
    Front Neurosci; 2022; 16():885031. PubMed ID: 35573295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
    Goyal D; Ali SA; Singh RK
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis.
    Fettig NM; Osborne LC
    Microbes Infect; 2021; 23(6-7):104814. PubMed ID: 33775860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome-mediated regulation of neuroinflammation.
    Bostick JW; Schonhoff AM; Mazmanian SK
    Curr Opin Immunol; 2022 Jun; 76():102177. PubMed ID: 35462279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.